These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11929838)

  • 1. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
    van Noesel MM; van Bezouw S; Salomons GS; Voûte PA; Pieters R; Baylin SB; Herman JG; Versteeg R
    Cancer Res; 2002 Apr; 62(7):2157-61. PubMed ID: 11929838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.
    Shivapurkar N; Toyooka S; Toyooka KO; Reddy J; Miyajima K; Suzuki M; Shigematsu H; Takahashi T; Parikh G; Pass HI; Chaudhary PM; Gazdar AF
    Int J Cancer; 2004 May; 109(5):786-92. PubMed ID: 14999791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustering of hypermethylated genes in neuroblastoma.
    van Noesel MM; van Bezouw S; Voûte PA; Herman JG; Pieters R; Versteeg R
    Genes Chromosomes Cancer; 2003 Nov; 38(3):226-33. PubMed ID: 14506696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of DcR1, DcR2, DR4, DR5 gene promoters and clinical significance in tongue carcinoma.
    Zhou Y; Zheng S; Luo Q; Huang X; Zhou Y; Li Z
    Am J Otolaryngol; 2019; 40(6):102258. PubMed ID: 31399243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
    Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
    Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
    Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
    Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.
    Venza M; Visalli M; Catalano T; Fortunato C; Oteri R; Teti D; Venza I
    Biochem Biophys Res Commun; 2013 Nov; 441(4):743-50. PubMed ID: 24211571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of a set of monoclonal antibodies to TRAIL and TRAIL receptors DR4, DR5, DcR1, and DcR2.
    Liu XS; Zhu Y; Han WN; Li YN; Chen LH; Jia W; Song CJ; Liu F; Yang K; Li Q; Jin BQ
    Hybrid Hybridomics; 2003 Apr; 22(2):121-5. PubMed ID: 12831538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study.
    Gottwald L; Piekarski J; Kubiak R; Szwalski J; Pasz-Walczak G; Sęk P; Spych M; Suzin J; Tyliński W; Jeziorski A
    Arch Gynecol Obstet; 2013 Oct; 288(4):889-99. PubMed ID: 23584885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.
    Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG
    World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of apoptosis signaling by Apo2 ligand.
    Marsters SA; Pitti RA; Sheridan JP; Ashkenazi A
    Recent Prog Horm Res; 1999; 54():225-34. PubMed ID: 10548878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.
    Meng RD; McDonald ER; Sheikh MS; Fornace AJ; El-Deiry WS
    Mol Ther; 2000 Feb; 1(2):130-44. PubMed ID: 10933923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric carcinoma.
    Lee KH; Lim SW; Kim HG; Kim DY; Ryu SY; Joo JK; Kim JC; Lee JH
    Langenbecks Arch Surg; 2009 Jul; 394(4):661-70. PubMed ID: 19350268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1.
    Bernard D; Quatannens B; Vandenbunder B; Abbadie C
    J Biol Chem; 2001 Jul; 276(29):27322-8. PubMed ID: 11350953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.
    Margetts CD; Astuti D; Gentle DC; Cooper WN; Cascon A; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
    Endocr Relat Cancer; 2005 Mar; 12(1):161-72. PubMed ID: 15788647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism.
    Pei GT; Wu CW; Lin WW
    Biochem Biophys Res Commun; 2010 Jan; 391(2):1274-9. PubMed ID: 20018172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
    Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
    BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of different receptors of the apoptosis inducing gene TRAIL in human ovarian tumors].
    Li XG; Zhang Y; Chen BL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):471-3. PubMed ID: 12212122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.